How to Choose the Right Solubilisation Technology for an API
The proportion of poorly soluble drug compounds in the development pipeline is on the rise,...
By Neil Jones
The challenge of taking a drug candidate from discovery through to market should not be underestimated, as there can be many hurdles to face along the path.
This article discusses how the careful use of external contractors during development can alleviate some of these challenges.
The proportion of poorly soluble drug compounds in the development pipeline is on the rise,...
Patheon has made an initial public offering of 30,487,805 of its ordinary sharesThis figure is...
Patheon has announced it has signed a manufacturing agreement with Amgen, one of the world's...
Patheon has signed a strategic agreement with Grünenthal, an independent, family-owned, international research-based pharmaceutical group...